Imunon Inc (IMNN)
1.33
+0.02
(+1.53%)
USD |
NASDAQ |
May 03, 16:00
1.35
+0.02
(+1.50%)
After-Hours: 20:00
Imunon Cash from Investing (TTM): 11.01M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.01M |
September 30, 2023 | 3.425M |
June 30, 2023 | -2.342M |
March 31, 2023 | -7.952M |
December 31, 2022 | 8.281M |
September 30, 2022 | 18.19M |
June 30, 2022 | 16.30M |
March 31, 2022 | 1.755M |
December 31, 2021 | -30.12M |
September 30, 2021 | -29.15M |
June 30, 2021 | -29.38M |
March 31, 2021 | -5.252M |
December 31, 2020 | 7.924M |
September 30, 2020 | 10.23M |
June 30, 2020 | 12.73M |
March 31, 2020 | 9.984M |
December 31, 2019 | 5.936M |
September 30, 2019 | 7.909M |
June 30, 2019 | -2.485M |
March 31, 2019 | -1.889M |
December 31, 2018 | -1.632M |
September 30, 2018 | -18.66M |
June 30, 2018 | -13.54M |
March 31, 2018 | -18.39M |
December 31, 2017 | -10.99M |
Date | Value |
---|---|
September 30, 2017 | 4.584M |
June 30, 2017 | 2.222M |
March 31, 2017 | -0.0584M |
December 31, 2016 | 9.061M |
September 30, 2016 | 12.21M |
June 30, 2016 | 16.52M |
March 31, 2016 | 22.36M |
December 31, 2015 | 13.33M |
September 30, 2015 | 22.00M |
June 30, 2015 | 20.84M |
March 31, 2015 | 21.39M |
December 31, 2014 | 9.544M |
September 30, 2014 | -9.558M |
June 30, 2014 | -0.0741M |
March 31, 2014 | -22.04M |
December 31, 2013 | -29.14M |
September 30, 2013 | -18.89M |
June 30, 2013 | -31.19M |
March 31, 2013 | -10.48M |
December 31, 2012 | 1.471M |
September 30, 2012 | -4.796M |
June 30, 2012 | -13.50M |
March 31, 2012 | -16.64M |
December 31, 2011 | -11.09M |
September 30, 2011 | -9.592M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-30.12M
Minimum
Dec 2021
18.19M
Maximum
Sep 2022
0.3673M
Average
5.936M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
Avalo Therapeutics Inc | -0.133M |
iBio Inc | 8.285M |
Ocugen Inc | 3.077M |
Petros Pharmaceuticals Inc | -- |
Moderna Inc | 2.313B |